# Glooko

> Glooko is a diabetes software company that combines data from more than 200 diabetes and health monitoring devices for patients, clinicians and researchers. Its portfolio spans outpatient data management, a free patient mobile app, clinical trial tools, French remote monitoring platform Glooko XT and, through Monarch Medical Technologies, inpatient insulin-dosing software EndoTool.

- **Founded:** 2010
- **Headquarters:** Palo Alto, United States
- **Founders:** Yogen Dalal (Co-founder; former interim CEO and chairman), Sundeep Madra (Co-founder), Chamath Palihapitiya (Co-founder)
- **Products:** Glooko outpatient platform / GlookoCare, Glooko Mobile App, Glooko XT, EndoTool Glucose Management System, EndoTool IV Cloud
- **Notable:** 200-plus integrated diabetes and health monitoring devices., Reported cumulative reach of 4.4 million-plus patients and 10,000-plus clinics on its 2024 financing page., 2026 MedTech Breakthrough Best Overall MedTech Software award.

## Products & services

- **Glooko outpatient platform / GlookoCare** — Device-neutral diabetes data aggregation, population review, remote collaboration and EHR integration for clinical teams.
- **Glooko Mobile App** — Free patient app for syncing compatible devices, viewing trends and logging food, activity and medication; the original logbook launched in 2011.
- **Glooko XT** — French remote patient monitoring platform derived from DIABNEXT, acquired in March 2022.
- **EndoTool Glucose Management System** — Monarch Medical Technologies inpatient insulin-dosing and glycemic-management software; joined Glooko through the September 2025 acquisition.
- **EndoTool IV Cloud** — FDA 510(k)-cleared cloud-based hospital IV insulin-dosing decision support; announced May 2026, with U.S. commercial launch expected before year end.
- **GestationalCare** — Pregnancy-specific module for risk prioritization, fasting and post-meal review, engagement and postpartum transition; available in the UK at announcement, with U.S. availability planned for October 2026.
- **Clinical trials and real-world data services** — Remote device data collection, trial data management and evidence-development tools for life sciences organizations.

## Achievements

- 200-plus integrated diabetes and health monitoring devices.
- Reported cumulative reach of 4.4 million-plus patients and 10,000-plus clinics on its 2024 financing page.
- 2026 MedTech Breakthrough Best Overall MedTech Software award.
- FDA 510(k) clearance announced for EndoTool IV Cloud in May 2026.
- Epic Showroom listing announced in February 2025.

## Latest updates

- **2026-09** — Announced GestationalCare, available in the UK with U.S. availability planned for October 2026.
- **2026-06** — Announced EHR integration for discrete insulin pump settings.
- **2026-05** — Announced FDA 510(k) clearance for EndoTool IV Cloud and a planned U.S. commercial launch before the end of 2026.
- **2026-05** — Expanded partnership with mylife Diabetes Care as its primary data management platform.

## Links

- Website: https://glooko.com/
- LinkedIn: https://www.linkedin.com/company/glooko/
- Twitter/X: https://x.com/GlookoInc
- YouTube: https://www.youtube.com/channel/UCad9qmgFMDg1MsRHGCLgSuA
- Instagram: https://www.instagram.com/glooko/
- Facebook: https://www.facebook.com/Glooko/

---

Profile page: https://yespress.io/glooko
Published by YesPress — https://yespress.io
Last updated: 2026-10-01